Clinical trial
Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not…
NCT00095030 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00095030 |
|---|---|
| Title | Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin Alone |
| Official title | A Phase 3, Randomized, Three-Arm, Double-blind, Active Controlled, Parallel Group, Multicenter Trial to Evaluate the Safety and Efficacy of Muraglitazar in Combination With Metformin Compared to Glimepiride in Combination With Metformin in Subjects Wtih Type 2 Diabetes Who Have Inadequate Glycemic… |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Collaborators | Merck Sharp & Dohme LLC Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | muraglitazar |
| Enrollment | 1,752 |
| Start date | Feb 1, 2004 |
| Primary completion | Mar 1, 2006 |
| Completion | Mar 1, 2006 |
| First posted | Nov 1, 2004 |
| Last update posted | Sep 14, 2010 |
| Countries | Argentina, Austria, Brazil, Canada, Chile, Germany, Hong Kong, Mexico, Peru, Philippines, Poland, Puerto Rico and 5 more |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: